secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2026-07-13T20:01:13+00:00
Accession:  0001193125-26-301997
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics effects 1-for-200 reverse stock split; shares to trade under GRTXD on OTCQB
--------------------------------------------------------------------------------

- Reverse stock split of common stock at 1:200 ratio effective July 12, 2026.
- No fractional shares; stockholders receive cash value based on closing price prior to split.
- Outstanding options and warrants adjusted proportionally with exercise price increases.
- Common stock begins trading on OTCQB under ticker GRTXD on July 13, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526301997/0001193125-26-301997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526301997/d155293d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-301997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer